Immunotherapy in Cancer: Mechanisms and Strategies to Overcome Resistance

Drug Resistance Updates · Published 2026-07-01 · DOI 10.1016/j.drup.2026.101447

Authors (8)

Haigan Yang, Zhehan Yang, Xianzhe Wang, Harsh Patel, Zhuo-Xun Wu, Charles R. Ashby, Wei Wang, Zhe-Sheng Chen

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Yang, H., Yang, Z., Wang, X., et al. (2026). Immunotherapy in Cancer: Mechanisms and Strategies to Overcome Resistance. Drug Resistance Updates. https://doi.org/10.1016/j.drup.2026.101447

Related articles

• Tailored HER2 ECD mRNA-LNP vaccines boost CD8+ T cell-mediated antitumor immunity for HER2-positive tumor suppression · Drug Resistance Updates · 2026 · Same journal
• Resistance to CAR-based cell therapy: Mechanisms and overcoming strategies · Drug Resistance Updates · 2026 · Same journal
• Low dose radiation induces new protein synthesis that promotes cancer radiotherapy resistance · Drug Resistance Updates · 2026 · Same journal
• Long-term outcomes and exploratory analysis from a randomized phase 3 trial of radiation dose escalation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma · Drug Resistance Updates · 2026 · Same journal
• ZBED6-Driven Nucleotide Metabolic Reprogramming Improves Sensitivity to anti-PD1 Therapy in NK/T Cell Lymphoma · Drug Resistance Updates · 2026 · Same journal
• PRKCA and ABCB1 dual-enriched exosomes are key drivers of drug resistance in chronic myeloid leukemia · Drug Resistance Updates · 2026 · Same journal
• Mechanistic analysis on epigenetic programming of tumor drug resistance · Drug Resistance Updates · 2026 · Same journal
• NHE6-driven endosome-autophagy axis confers proteasome inhibitor resistance in multiple myeloma · Drug Resistance Updates · 2026 · Same journal
• Resensitizing drug-resistant cancers by co-targeting apoptosis and mitochondrial stress pathway · Drug Resistance Updates · 2026 · Same journal
• Targeting hyaluronan synthesis sensitizes anti-PD1 immunotherapy in cancer · Drug Resistance Updates · 2026 · Same journal